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Activity of protein phosphatase measured in the absence of divalent cations was decreased by 50% during all-tram retinoic acid (ATRA)-induced 
HL-60 cell differentiation i to the granulocytic phenotype. Treatment of HL-60 cells with ATRA led to a dramatic decrease in the amount of protein 
phosphatase type 2A (PP2A) protein, whereas that of protein phosphatase type 1 (PPl) protein was relatively constant, as detected by immunoblot- 
ting with antibodies pecific to PPl and PPZA. The decreased phosphatase activity may be mainly due to a decrease in the expression of the PP2A 
protein. The mRNA level of PP2A@ was markedly decreased within 5 h after addition of ATRA, but there was only a slight increase in the mRNA 
level of PP2Au. Selective down-regulation of PP2qB mRNA clearly preceded the cell differentiation induced by ATRA treatment. Thus, PP2A 
is down-regulated uring ATRA-induced differentiation of HL-60 cells into granulocytes. 
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1. INTRODUCTION 
All-tram retinoic acid (ATRA) induces human my- 
elogenous leukemic HL-60 cells [1,2], as well as fresh 
acute promyelocytic leukemia blast cells [3,4], to differ- 
entiate terminally into mature granulocytes. ATRA 
binds to specific nuclear receptors (RA receptors), and 
the ATRA-RA receptor complex possibly regulates the 
transcription of target genes in a manner similar to that 
seen with steroid/thyroid hormones [5]. Little is known 
of intracellular events that initiate the process leading 
to cessation of proliferation and to terminal differentia- 
tion of HL-60 cells, subsequent to ATRA-RA receptor 
interaction. Protein kinase C activation and modulation 
of its isozyme expression is thought to play important 
roles in regulating the response of HL-60 cells to vari- 
ous inducers of differentiation [6]. Although critical 
substrates for phosphorylation by protein kinase C, 
which subsequently mediate differentiation, have not 
been conclusively identified, the regulation of the pro- 
tein function by phosphorylation necessarily requires 
protein phosphatases in addition to protein kinases. It 
is therefore conceivable that protein phosphatases may 
also be involved in the process of HL-60 cell differenti- 
ation. The major serine/threonine protein phosphatase 
catalytic subunits of mammalian cells comprise four 
Correspondence address: M. Nishikawa, The Second Department of 
Internal Medicine, Mie University School of Medicine, Tsu, Mie 514, 
Japan. Fax: (81) (592) 31 5200. 
forms which have been designated as type 1 (PPl), type 
2A (PP2A), type 2B (calcineurin) and type 2C, based on 
a classification system proposed by Cohen [7,8]. PPl 
and PP2A do not have an absolute requirement for 
divalent cations, whereas protein phosphatases type 2B 
and type 2C are Ca2+/calmodulin- and Mg2+-dependent, 
respectively. PPl and PP2A are known to dephospho- 
rylate many proteins in vitro and are likely to have 
pleotropic actions in vivo [8]. Recently, we have re- 
ported that okadaic acid [9,10] and calyculin-A [l 1,121, 
both potent and specific inhibitors of PPl and PP2A, 
augment he granulocytic differentiation of HL-60 cells 
induced by ATRA, but not the monocytic differentia- 
tion induced by 12-o-tetradecanoyl phorbol 13-acetate 
(TPA) [13]. To further elucidate the involvement of PPl 
and PP2A in HL-60 cell differentiation, we investigated 
changes in phosphatase activity and expression patterns 
of PPl and PP2A proteins and mRNA expressions of 
PP2A isoforms during the granulocytic differentiation 
induced by ATRA. 
2. MATERIALS AND METHODS 
2.1. Materials 
ATRA and TPA purchased from Sigma Chemical Co. (St. Louis, 
MO) were dissolved in ethanol (lo-’ M) and diiethylsulfoxide (10m4 
M) respectively, and stored at -20°C with protection from light. 
2.2. Determination of cell differentiation 
Procedures used for the maintenance of HL-60 cells and determina- 
tion of viable cell counts were as described elsewhere [14]. The extent 
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of differentiation was assessed by morphology, the ability to produce 
superoxide as monitored by the reduction of NBT (Nitroblue tetra- 
zolium, Sigma). For morphological assessment, cytospin slide prepa- 
rations of the cells were stained with May-Giemsa and examined under 
a microscope. The extent of NBT reduction was evaluated as described 
elsewhere [15]. I 
2.3. Preparation of cytosolic fraction andphosphatase activity 
a All preparative procedures were carried out at 4°C. HL-60 (2 x lo8 
cells) were homogenized in a buffer containing 20 mM Tris-HCl, pH 
7.4,2 mM dithiothreitol, 2 mM EDTA, 2 mM EGTA, 0.25 M sucrose 
and a cocktail of protease inhibitors [14], by a glass to glass Potter- 
Elvehjem homogenizer. The homogenates were immediately centri- 
fuged at 1,000 x g for 10 min and the supernatant was centrifuged at 
100,000 x g for 1 h. The resulting supernatant was used as the cytosolic 
fraction. 
32P-phosphorylated myosin light chains were used as substrates of 
the phosphatase assay because these are good substrates for both 
mammalian PPl and PP2A [ 161. Phosphatase activity was determined 
by the liberation of ‘*P, from the substrates (“P-1abelled 20 kDa 
myosin light chain) at 30°C according to the methods of Pato and 
Kerc [17]. The extent of dephosphorylation was restricted to below 
10%. Under these conditions rates of dephosphorylation were linear 
with respect o time and enzyme dilution. 
2.4. Immunoblot analysis 
Antisera against PPl or PP2A was obtained by immunizing a rabbit 
with the synthesized fragments of PPl or PP2A [18,19]. HL-60 cells 
were incubated with ATRA (1 PM) or TPA (20 nM), and the reaction 
was stopped by adding ice-cold trichloroacetic acid (10% final con- 
centration). Acid-precipitated proteins were washed in acetone and 
subjected to SDS-PAGE using a 12.5% running gel followed by elec- 
trophoretical transfer onto Immobilon polyvinyliden difluoride mem- 
brane (Millipore, Bedford, MA). The membrane was reacted with 
specific antibodies for PPl and PP2A, and immunoreactive proteins 
were stained using the avidin-biotin peroxidase complex method (Vec- 
tastain, Vector Laboratories, Burlingame, CA). Quantitative stima- 
tion of the level of PPl and PP2A was carried out densitometrically 
with a Bio-Rad video-densitometer by scanning the immunoreactive 
band after immediately photographing the visualized band. The area 
of an individual peak was measured above background in densitomet- 
ric tracings and expressed as A x mm [20]. 
2.5. RNA isolation and Northern blot analysb 
Total cellular RNA was extracted using the guanidinium isothiocy- 
anate technique [21]. Twenty pg of total RNA of HL-60 cells was 
electrophoresed through 0.8% agarose with 18% formaldehyde, and 
transferred to Nytran membranes (Schbicher and Schuell, Dassel, 
Germany). After being baked at 9YC for 2 h under vacuum, blots 
were hybridized at 42°C in 50% formamide, 5 x Denhardt’s solution, 
5 xSSPE (1 xSSPE; 0.15 M NaCl, 10 mM NaH2P0,, 0.1 mM 
EDTA), 0.5% SDS, 200 &ml of denatured salmon sperm DNA, and 
the 32P-labeled cDNA probe. The probes used were the full-length 
cDNA of the rat PP2Aa and PP2Ag [22] and labeled with [y-3ZP]dCTP 
by a multiprime labeling system kit (Amersham, Buckinghamshire, 
UK). Hybridized blots were finally washed with 0.1 x SSC (standard 
saline citrate), (1 x SSC; 0.15 M NaCI, 15 mM trisodium citrate), 0.5% 
SDS at room temperature and autoradiographed. Quantification of 
hybridization was determined by scanning densitometry. 
3. RESULTS AND DISCUSSION 
ATRA suppressed the proliferation of HL-60 cells 
and induced these cells to differentiate terminally into 
granulocytes. Morphologic examination of Giemsa- 
stained cytospin preparations showed that untreated 
HL-60 cells retained a blast-like phenotype throughout 
0 1 2 3 4 5 
Time(Days) 
Fig. 1. Time-dependent differentiation of HL-60 cells induced by 1 PM 
ATRA. Differentiation of HL-60 cells was determined by the NBT 
reduction test. Each point represents the mean + S.D. from four sep- 
arate experiments. 
all the experiments, whereas the ATRA-treated cells 
gradually acquired a differentiated morphology, exhib- 
iting a metamyelocyte (26%), or granulocytic (38%) 
morphology and ability to reduce NBT from 3 to 52% 
after 5 days of treatment (Fig. 1). 
The activity of serine/threonine protein phosphatase 
in HL-60 cells was assayed in the absence of divalent 
cations, using 32P-phosphorylated myosin light chain of 
smooth muscle as substrate, a good substrate for both 
mammalian PPl and PP2A [16]. Alteration of phos- 
phatase activity was examined in cytosolic fractions be- 
cause phosphatase activity was found to be most abun- 
dant in these fractions (approx. 60%) [13]. HL-60 cells 
were grown in the presence and absence of 1 ,uM ATRA 
and harvested for the measurement of phosphatase ac- 
tivity, at various times (Fig. 2). The addition of ATRA 
to exponentially growing HL-60 cells resulted in a grad- 
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Fig. 2. Time course of protein phosphatase activity during ATRA- 
induced differentiation of HL-60 cells. HL-60 cells (2 x lo8 cells) were 
treated with 1 PM ATRA, and cytosolic fractions were prepared at 
the indicated time. Protein phosphatase activity was measured as 
described in section 2. Each point represents the mean f S.D. from 
three separate xperiments. 
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Fig. 3. Time course of changes in immunoreactive PPl and PPZA 
during ATRA-induced differentiation of HL-60 cells. HL-60 cells 
(1 x lo* cells) were treated with 1 PM ATRA and the incubation was 
halted by adding ice-cold trichloroacetic acid at the indicated periods 
of time below the corresponding lanes. The acid-precipitated proteins 
were analyzed by immunoblot analysis, using antisera specific for PPl 
(panel A), and PP2A (panel B) as described in section 2. Molecular 
weight standards (M, x lo-‘) are shown on the left. Panel C: graphic 
display of PPl (0) and PP2A (0) shown in panel A and panel B, as 
quantitated by densitometry. Although these data are from one repre- 
sentative xperiment, similar results were obtained in two other exper- 
iments. 
ual decrease in cytosolic phosphatase activity and the 
activity reached the lowest level (approx. 52% decrease 
relative to that in untreated HL-60 cells) 3 days after 
ATRA treatment. Decrease in phosphatase activity ap- 
peared to be coincidental with increase in the percentage 
of NBT-positive cells. These data suggest that the de- 
crease in phosphatase activity may be associated with 
the ATRA-induced differentiation of HL-60 cells. 
To determine whether either PPl or PP2A or both are 
decreased after treatment with ATRA, expressions of 
these proteins in whole cell extracts were investigated by 
Western blot analysis using polyclonal antibodies spe- 
cific for PPl and PP2A catalytic subunits. As shown in 
Fig. 3, PP2A was detected as a major single im- 
munoreactive band of M, = 33 kDa and PPl as a major 
single band of 44, = 32 kDa, respectively. The time- 
dependent dramatic decrease in immunoreactive PP2A 
was evident after the addition of ATRA. Translocation 
of PP2A from the cytosol fraction to plasma membrane 
or nuclear fraction was not evident (data not shown). 
In contrast, there was only a slight decrease in the 
amount of PPl (Fig. 3). Thus, the expression of PPl and 
PP2A appeared to be separately modulated in the proc- 
ess of ATRA-induced granulocytic differentiation, and 
the decreased phosphatase activity might be mainly due 
to a decrease in the expression of PP2A protein. How- 
ever, the loss of phosphatase activity of HL-60 cells 
following exposure to ATRA may not be fully explained 
by a decrease in the expression of PP2A protein and our 
studies do not exclude the possibility that other factors 
may influence the phosphatase activity. PPl and PP2A 
isolated in various forms from mammalian tissues are 
composed of catalytic and regulatory subunits [8]. The 
activity or substrate specificity of the phosphatases may 
be altered by modification or interaction with regula- 
tory proteins, without change in the level of expression, 
0 12 24 48 (hr) 
Fig. 4. Time course of changes in immunoreactive PP2A during TPA- 
induced monocytic differentiation of HL-60 cells. HL-60 cells (1 x 10’ 
cells) were treated with 20 nM TPA for the indicated periods of time 
below the corresponding lanes. Immunoblot analysis were performed 
as in section 2. Molecular weight standards (kf, x 10e3) are shown on 
the left. The result shown is representative of three independent exper- 
iments. 
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A 
although these regulatory proteins remain to be fully 
characterized. Determination of whether these other 
subunits have important roles in directing the subcellu- 
lar location and the modulation of specificity and regu- 
latory behaviour of these enzymes, will be a prerequisite 
to understanding the control of dephosphorylation 
processes in HL-60 cells. The down-regulation of PP2A 
is, at least in part, thought to contribute to the decrease 
in phosphatase activity during the ATRA-induced dif- 
ferentiation of HL-60 cells. In contrast, the expression 
of PP2A protein was unaltered in the course of TPA- 
induced monocytic differentiation as shown in Fig. 4. 
Treatment of HL-60 cells with 20 nM TPA for 2 days 
led to acquisition of the phenotype of a mature mon- 
ocyte. 
ATRA(1pM) g# 
(W 0 1 3 5 12 24 2 
- 20s 
2.0kb - 
April 1993 
B ATRA(lpM) 
t 1 
(h) 0 1 3 5 12 24 
-28s 
2.Okb- 
-18s 
c 4p(--E-y 
Ol.“‘.‘~“.“~J 
0 6 12 18 24 
Time(Hours) 
There are at least two genes encoding isoforms of 
PP2A, PP2Aa and PP2A/?, identified at various ratios 
in mammalian tissues [23]. The isoforms of PP2A have 
a > 97% identity of amino acids and there is currently 
no information on possible functional differences. To 
determine whether the ATRA-induced down-regulation 
of PP2A of HL-60 cells was reflected at the level in RNA 
transcripts, Northern blot analysis using radiolabeled 
rat PP2A isoform-specific DNA probes were made on 
total cellular RNA obtained from ATRA-treated HL- 
60 cells (Fig. 5). After hybridization to the PP2A/I 
probe, two bands of approx. 2.0 kb and 1.2 kb were 
observed, and the 2.0 kb mRNA was a major transcript 
in HL-60 cells (Fig. 5B). In HL-60 cells, the down regu- 
lation of the PP2A,8 was evident within 3 h after the 
addition of ATRA. The level of PP2qS mRNA was 
further decreased to approx. one-third of the basal level 
of untreated HL-60 cells within 5 h, as normalized to the 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
mRNA expression (Fig. 5C). Decreased PP2A/? expres- 
sion continued throughout the course of ATRA treat- 
ment. Rehybridization of these blots with the GAPDH 
cDNA probe contirmed that relatively equal amounts 
of RNA were loaded in each lane. The change in PP2v 
mRNA was complete within 5 h, while the decrease in 
immunoreactive PP2A occurred over 2 days, suggesting 
t 
Fig. 5. Time course of PPZA isotype PPZA and PP2A mRNA expres- 
sion in HL-60 cells stimulated with ATRA. HL-60 cells (2 x 10’ cells) 
were treated with 1 PM ATRA. Total RNA (20 rg) was isolated from 
HL-60 cells at the indicated periods of time below the corresponding 
lanes. Northern blots of total RNA were hybridized to “P-labeled 
PP2Aa (panel A) and PPZA/7 (panel B) cDNA probes. The same RNA 
blots were hybridized to GAPDH cDNA probe for assessment of 
RNA quantities in each lane (bottom). The positions of the 28 S and 
18 S ribosomal RNAs are indicated. Panel C: graphic representation 
of relative intensity of hybridization signals of PP2Aa (& and PP2A/3 
(m) obtained from densitometric scanning of the autoradiogram pic- 
tured in panels A and B. The ratio of PP2Aa and PP2A@ specific 
signals to the GAPDH signal was determined for each time point 
following ATRA addition and the resulting value is designated as 
relative intensity. Similar results were obtained in two independent 
experiments. 
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the long half-life of PP2A protein. The down-regulation 
of PP2A/I mRNA expression clearly preceded the 
ATRA-induced HL-60 cell differentiation as monitored 
by NBT reduction. The PP2Aa probe also detected a 
major band of 2.0 kb and minor band of 3.0 kb in L929 
mouse fibroblast RNA (Fig. 5A). In HL-60 cells, the 2.0 
kb transcript was weakly expressed, and the expression 
of the PP2Aoz 2.0 kb transcript was relatively unaltered 
by ATRA treatment. Other investigators found that the 
expression of PP2Aol mRNA is also unaltered after ad- 
dition of the monocyte inducer TPA to HL-60 cells [24], 
although expression of PP2A/? mRNA was not exam- 
ined. The present data suggest that the two isotypes of 
PP2A could be differently regulated during ATRA-in- 
duced differentiation. 
A growing body of evidence suggests important roles 
of protein phosphatases as well as protein kinases in the 
growth control of cells [25]. Differentiation of HL-60 
cells by chemical agents such as ATRA, 1,25-dihy- 
droxyvitamin D, and phorbol diester is always accom- 
panied by withdrawal from the cell cycle [2]. The expres- 
sion of many genes are known to be regulated during 
HL-60 cell differentiation [26]. The change in PP2A/3 
mRNA may be the result of, rather than the cause of, 
differentiation. However, we reported that two potent 
inhibitors of PPl and PP2A, okadaic acid and calyculin- 
A, augment ATRA-induced granulocytic differentia- 
tion of HL-60 cells, but have no effect on the monocytic 
differentiation induced by phorbol diester [13]. PP2A is 
thought to regulate multiple functions in vivo, including 
several metabolic pathways, protein synthesis, DNA 
replication and the cell cycle [8]. Consistent with this 
hypothesis, abundant transcripts of PP2qS are present 
in untreated HL-60 cells, and it is of interest that tran- 
scripts of PP2qB are decreased at the initial steps of 
ATRA-induced differentiation. It is possible that down- 
regulation of PP2A may be involved in ATRA-induced 
differentiation of HL-60 cells toward granulocytes. In 
ongoing studies, we are examining modulation/expres- 
sion of phosphatases by other differentiation inducers 
in order to establish the regulatory roles of 
phosphatases in cellular signalling of HL-60 cell differ- 
entiation. 
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